What's New in Photon Counting CT? — October 20, 2026
AI-summarised digest of 9 PubMed articles on Photon Counting CT published in the last 7 days.
Jump to category
What’s New in Photon Counting CT?
October 20, 2026 · 9 articles · 9 research themes · covering October 13, 2026 – October 20, 2026
Overview
Across this week’s set of studies and reviews, a clear theme is the rapid expansion of CT—especially photon-counting CT (PCCT) and related detector technologies—into more comprehensive, quantitative, and protocol-driven clinical decision-making. Cardiac CT is increasingly positioned as a first-line strategy for stable chest pain and suspected chronic coronary syndromes, not only to exclude obstructive disease but also to characterize atherosclerotic burden and support preventive and downstream invasive management. In parallel, multiple PCCT-focused works emphasize that detector hardware, acquisition mode, reconstruction strategy, and contrast phase can materially change what clinicians measure (e.g., coronary stenosis grading, carotid body detectability/size, and the risk of false-positive carotid web interpretation).
Another dominant thread is “safer imaging through smarter protocols,” including dose reduction and iodine minimization without sacrificing diagnostic performance. Evidence syntheses for low-iodine dual-energy CT pulmonary angiography (DECT CTPA) propose a structured framework to tailor scanning based on image quality, diagnostic performance, and clinical outcomes. Complementing this, feasibility and optimization studies show that low-dose tin-filtered PCCT can preserve quantitative interstitial lung disease (ILD) assessment in inflammatory idiopathic myopathy, and that acquisition-mode selection in photon-counting coronary CT angiography can balance stenosis evaluation quality with radiation exposure.
Finally, several articles highlight the growing role of imaging biomarkers and radiomics—while also underscoring reproducibility challenges. PCCT-derived iodine metrics in rectal cancer are re-evaluated against MRI diffusion measures to better align iodine quantification with treatment response. Preclinical radiomics work in aging mice demonstrates that radiomic age signatures depend on platform and reconstruction choices, reinforcing the need for harmonization. Together, these findings point toward a future where CT is not just diagnostic imaging, but a standardized quantitative tool—provided that technical variability is systematically controlled.
Cardiac CT for Coronary & Structural Heart Disease
The evolving role of cardiac CT: Emerging technologies and clinical impact.
This review studied the expanding clinical role of cardiac computed tomography (CT), focusing on coronary CT angiography (CCTA) and newer cardiac CT technologies across patient populations with stable chest pain or suspected chronic coronary syndromes. It found that CCTA is increasingly endorsed as a first-line test because it can exclude obstructive coronary artery disease, characterize coronary atherosclerotic burden, support preventive therapy, and guide referral for invasive coronary angiography, while cardiac CT is also moving beyond luminal stenosis assessment. This matters clinically because it positions cardiac CT as a comprehensive platform for coronary, myocardial, valvular, and structural heart disease risk stratification and management planning.
Oda S, Iima M, Yanagawa M et al. · Diagnostic and interventional imaging · (2026) · View on PubMed ↗
Photon-Counting CT (PCCT) Acquisition & Reconstruction Optimization
Impact of Photon-Counting CT Acquisition Modes on Coronary Stenosis Assessment and Radiation Dose: A Phantom and Clinical Evaluation.
This phantom and clinical evaluation studied how different photon-counting detector CT (PCD-CT) acquisition modes affect coronary stenosis assessment and radiation dose in coronary CT angiography (cCTA). Using a first-generation dual-source PCD-CT with acquisition modes including Flash (high-pitch spiral with prospective ECG-gating), Sequence, Spiral, and retrospective ultra-high-resolution (UHR) spiral, the study compared image quality, blooming, stenosis grading, diagnostic accuracy, and dose. The significance is that selecting the optimal PCD-CT acquisition mode can improve coronary stenosis evaluation while managing radiation exposure, supporting safer implementation of photon-counting cCTA protocols.
Stein T, Lang F, Bamberg F et al. · Zeitschrift fur medizinische Physik · (2026) · View on PubMed ↗ · Free PDF ↗
Low-Iodine / Dose-Reduction CT Protocols
Dual-energy computed tomography pulmonary angiography for pulmonary embolism: a three-tier evidence framework to guide individualized low-iodine scanning.
This narrative review studied dual-energy CT pulmonary angiography (DECTPA/DECT CTPA) for pulmonary embolism (PE) and synthesized evidence to guide individualized low-iodine scanning strategies. It found that heterogeneous protocols across platforms and study designs can be organized into a three-tier framework—image quality, diagnostic performance, and clinical outcomes—to support tailored low-iodine acquisition approaches. The significance is that this evidence framework can help standardize how clinicians choose low-iodine DECT CTPA protocols to maintain diagnostic quality while reducing iodine load.
Jiang Q, Qian L · Diagnostic and interventional radiology (Ankara, Turkey) · (2026) · View on PubMed ↗ · Free PDF ↗
Carotid Imaging: Detection of Carotid Body & Carotid Web
Carotid Body Detection Rate and Size on Photon-Counting Versus Energy-Integrating Detector CT.
This retrospective study compared carotid body (CB) detection rate and size on photon-counting CT (PCCT) versus energy-integrating detector CT (EIDCT) in 48 adult patients undergoing head-and-neck CTA on both modalities at arterial and venous phases. PCCT and EIDCT were evaluated with mixed-effects models to determine how modality, imaging phase, and laterality affected CB detectability and measured size. The significance is that detector technology and contrast phase may change the reliability of CB visualization and quantification, which is important for future imaging-based assessment of carotid body–related physiology and disease.
Unger RH, Arizono E, Buch K et al. · AJNR. American journal of neuroradiology · (2026) · View on PubMed ↗
Ultra-high-resolution photon-counting CT argues against a suspected bilateral carotid web: a case report.
This case report studied a 75-year-old woman with transient ischemic attack and a suspected bilateral carotid web, comparing carotid CTA findings across prior dual-energy energy-integrating detector CT (EID-CT) and at-presentation stroke-protocol photon-counting detector CT (PCD-CT), with additional ultra-high-resolution reconstruction. The key finding was that the bilateral web-like appearance could be explained by reconstruction/acquisition factors rather than a true carotid web. This is significant because it highlights how photon-counting and ultra-high-resolution CT can reduce false-positive carotid web diagnoses that may otherwise lead to inappropriate management.
Ben-David E, Bogot NR, Berrebi Y et al. · Emergency radiology · (2026) · View on PubMed ↗
Oncology Imaging Biomarkers & Treatment Response
Photon-counting computed tomography and magnetic resonance imaging in rectal cancer: reassessment of normalized iodine concentration and apparent diffusion coefficient in an expanded cohort.
This single-center retrospective study assessed whether pretreatment photon-counting CT (PCCT)–derived normalized iodine concentration (NIC) in 63 patients with rectal adenocarcinoma could be reassessed using MRI-derived apparent diffusion coefficient (ADC) as an within-cohort reference for neoadjuvant treatment response. The key finding was that PCCT NIC performance for distinguishing Dworak tumor regression grades 0–1 (poor response) versus 2–4 (moderate/good response) was re-evaluated against MRI ADC, refining how iodine quantification relates to treatment response. This is significant because it supports more robust, imaging-biomarker–based prediction of response to neoadjuvant therapy in rectal cancer using PCCT and MRI ADC as complementary markers.
Saeed S, Shahzadi I, Niehoff JH et al. · Abdominal radiology (New York) · (2026) · View on PubMed ↗ · Free PDF ↗
Radiomics & Imaging Biomarker Reproducibility
Age-associated radiomic phenotyping in mice using multi-energy photon-counting and preclinical CT: an exploratory study.
This exploratory preclinical study investigated whether CT-derived radiomic features reflect chronological age patterns in female C57BL/6NRj mice across three age groups (28, 88, and 99 weeks) using multi-energy photon-counting CT (PCCT) and preclinical Albira II CT. It found that radiomic phenotyping performance depended on imaging platform and photon-counting CT reconstruction strategy when classifying age groups using nested leave-one-mouse-out cross-validation. The significance is that it clarifies how technical CT factors influence age-related radiomic signatures, which is crucial for reproducible radiomics in preclinical aging research.
Castioni NA, Wängler C, Mogler C et al. · Biogerontology · (2026) · View on PubMed ↗ · Free PDF ↗
Interstitial Lung Disease Quantification in Systemic Disease
Low-dose vs standard-dose photon-counting CT for myopathy-associated interstitial lung disease: a prospective feasibility study.
This prospective feasibility study evaluated whether low-dose tin-filtered photon-counting CT (PCCT) can quantify interstitial lung disease (ILD) burden in patients with inflammatory idiopathic myopathy (IIM), comparing low-dose (LD) versus standard-dose (SD) protocols and assessing ultrathin reconstructions. Using commercial deep-learning software (ContextFlow ADVANCE Chest CT) to extract quantitative ILD features from two consecutive PCCT scans, the study tested whether LD 1.0 mm reconstructions preserve quantitative assessment relative to SD 1.0 mm. The significance is that it supports dose reduction in PCCT for monitoring IIM-ILD while maintaining clinically useful quantitative imaging biomarkers.
Zhu Z, Xu K, Pang Y et al. · European radiology · (2026) · View on PubMed ↗
Temporal Bone & Cochlear Implant Imaging
Improved assessment of the cochlear implant and temporal bone structures with ultra-high resolution photon-counting detector CT compared to conventional CT systems.
This preclinical imaging study evaluated whether ultra-high-resolution photon-counting detector CT (PCD-CT) improves assessment of cochlear implant and temporal bone structures compared with conventional CT systems. Using three cochlear implant models in three post-mortem human specimen heads scanned on SOMATOM Edge, SOMATOM Force, and NAEOTOM Alpha with 192 reconstructions varying tube voltage (120–150 kV), tin filtration, slice thickness (0.2–0.6 mm), and reconstruction kernels, it quantified bone-to-soft-tissue contrast-to-noise ratio (CNR) and compared radiologist image quality. The significance is that optimized PCD-CT parameters may improve visualization around cochlear implants, supporting better temporal bone imaging for clinical planning and assessment.
van der Bie J, van der Eerden AW, van den Berg AS et al. · European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · (2026) · View on PubMed ↗ · Free PDF ↗
Generated automatically on October 20, 2026. Covers PubMed articles published October 13, 2026 – October 20, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.